Preparation of oleanolic acid nanosuspension

Chinese Pharmaceutical Journal

Volumn 41, Issue 12, 2006, Pages 924-927

  Chen, Ya Jun ^a   Yang, Xiang Liang ^a   Zhao, Xiao Ling ^a   Xu, Hui Bi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

High pressure homogenization; Nanosuspension; Oleanolic acid

Indexed keywords

OLEANOLIC ACID; SURFACTANT;

ARTICLE; DISSOLUTION; DRUG SOLUBILITY; DRUG SYNTHESIS; NANOPARTICLE; NANOTECHNOLOGY; PARTICLE SIZE; PRESSURE; SOLUBILITY; SUSPENSION;

EID: 33750925168     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. LIU J. Pharmacology of oleanolic acid and ursolic acid[J]. J Ethnopharmacol, 1995, 49: 57-68.
2. WANG B, JIANG C H. Studies on oleanolic acid[J]. Chin Pharm J 1992, 27(73): 393-395.
3. WANG D R. Progresses in the research of oleanolic acid[J]. Tianjin Pharm, 2003, 15(3): 56-58.
4. JIANG B, YIN C H. Measures of improving oral bioavailability of water-insoluble drugs[J]. Chin J Pharm, 2002, 33(7): 358-362.
5. KE X, PING Q N, ZHU Y. Dissolution improvement of cefuroxime axetil tablets by using micronization technology[J]. J China Pharm Univ, 2000, 31(3): 188-191.
6. LIVERSIDGE G G, CUNDY K C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: Absolute oral bioavailability of nanocrystalline danazol in beagle dogs[J]. Int J Pharma, 1995, 125: 91-97.
7. MÜLLER R H, JACOBS C, KAYSER O. Nanosuspensions as particulate drug delivery formulations in therapy. Rationale for development and what we can expect for the future[J]. Adv Drug Delivery Review, 2001, 47: 3-19.
8. LIVERSIDGE E M, LIVERSIDGE G G, COOPER E R. Nanosizing: a formulation approach for poorly-water-soluble compounds[J]. Eur J Pharm Sci, 2003, 18: 113-120.
9. MÜLLER R H, PETERS K. Nanosuspensions for the poorly soluble drugs I Preparation by a size reduction technique[J]. Int J Pharm, 1998, 160: 229-237.